Contemporary nationwide patterns of self-reported prostate-specific antigen screening in US veterans

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 12, 2015, Pages 503.e7-503.e15

  Pucheril, Daniel ^a   Sammon, Jesse D ^a   Sood, Akshay ^a   Abdollah, Firas ^a   Choueiri, Toni K ^b   Meyer, Christian ^b   Hanske, Julian ^b   Kim, Simon P ^c   Nguyen, Paul L ^b   Kibel, Adam S ^b   Weissman, Joel S ^d   Menon, Mani ^a   Trinh, Quoc Dien ^a,b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Prostate specific antigen; Screening; Veterans

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE SPECIFIC ANTIGEN SCREENING; SCREENING; SELF REPORT; UNITED STATES; VETERAN; MASS SCREENING; METABOLISM; MIDDLE AGED; RISK FACTOR;

AGED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; RISK FACTORS; SELF REPORT; UNITED STATES; VETERANS;

EID: 85004025730     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.07.019     Document Type: Article

References (36)

1. United States Census Bureau, The 2012 Statistical Abstract. National Security & Veterans Affairs: Veterans 2012; [accessed October 23, 2014, 2012]. http://www.census.gov/compendia/statab/cats/national_security_veterans_affairs/veterans.html.
2. Wilensky G.R. The roller-coaster image of the VA. Healthc Financ Manage 2014, 68:32. 30.
3. [accessed 17.10.14]. http://www.va.gov.
4. Devi S. Obama vows to address veteran health-care scandal. Lancet 2014, 384:841.
5. Carter H.B., Albertsen P.C., Barry M.J., et al. Early detection of prostate cancer: AUA Guideline. J Urol 2013, 190:419-426.
6. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014, 384:2027-2035.
7. Sammon J.D., Pucheril D., Diaz M., et al. Contemporary nationwide patterns of self-reported prostate-specific antigen screening. JAMA Intern Med. 2014, 174:1839-1841.
8. CDC/BRFSS. BRFSS overview 2012. ; 2012. http://www.cdc.gov/brfss/annual_data/2012/pdf/Overview_2012.pdf.
9. [accessed 11.12.13]. http://www.cdc.gov/br.
10. Sedgwick P. Interclass correlation coefficient. BMJ 2013, 346:f1816.
11. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
12. Kizer K.W., Dudley R.A. Extreme makeover: transformation of the veterans health care system. Annu Rev Public Health 2009, 30:313-339.
13. Jha A.K., Perlin J.B., Kizer K.W., Dudley R.A. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med 2003, 348:2218-2227.
14. Keyhani S., Ross J.S., Hebert P., Dellenbaugh C., Penrod J.D., Siu A.L. Use of preventive care by elderly male veterans receiving care through the Veterans, Medicare fee-for-service, and Medicare HMO plans. Am J Public Health 2007, 97:2179-2185.
15. Ross J.S., Keyhani S., Keenan P.S., et al. Use of recommended ambulatory care services: is the Veterans Affairs quality gap narrowing?. Arch Intern Med 2008, 168:950-958.
16. Ward E., Halpern M., Schrag N., et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008, 58:9-31.
17. Wee C.C., McCarthy E.P., Phillips R.S. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005, 41:23-29.
18. Klabunde C.N., Vernon S.W., Nadel M.R., Breen N., Seeff L.C., Brown M.L. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Medical Care 2005, 43:939-944.
19. Klabunde C.N., Schenck A.P., Davis W.W. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med 2006, 30:313-319.
20. Services USDoHH. About the law. ; 2014 [accessed 18.12.14]. http://www.hhs.gov/healthcare/rights/.
21. Aizer A.A., Falit B., Mendu M.L., et al. Cancer-specific outcomes among young adults without health insurance. J Clin Oncol 2014, 32:2025-2030.
22. Jemal A., Ward E., Wu X., Martin H.J., McLaughlin C.C., Thun M.J. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol Biomarkers Prev 2005, 14:590-595.
23. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
24. Chamie K., DeVere White R.W., Lee D., Ok J.H., Ellison L.M. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer 2008, 113:2464-2470.
25. Koepsell T., Reiber G., Simmons K.W. Behavioral risk factors and use of preventive services among veterans in Washington State. Prev Med 2002, 35:557-562.
26. Silberbogen A.K., Busby A.K., Ulloa E.W. Impact of psychological distress on prostate cancer screening in U.S. military veterans. Am J Mens Health 2013, 8:399-408.
27. Bagalman E. The number of veterans that use VA health care services: a fact sheet 2014.
28. Liu C.F., Maciejewski M.L., Sales A.E. Changes in characteristics of veterans using the VHA health care system between 1996 and 1999. Health Res Policy Syst 2005, 3:5.
29. Wilson N.J., Kizer K.W. The VA health care system: an unrecognized national safety net. Health Aff (Project Hope) 1997, 16:200-204.
30. Hynes D.M., Koelling K., Stroupe K., et al. Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care 2007, 45:214-223.
31. Moyer V.A. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012, 157:120-134.
32. Perez T.Y., Danzig M.R., Ghandour R.A., Badani K.K., Benson M.C., McKiernan J.M. Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices. Urology 2015, 85:85-89.
33. Goodwin J.S., Jaramillo E., Yang L., Kuo Y.F., Tan A. Is anyone listening? Variation in PSA screening among providers for men 75+before and after United States Preventive Services Task Force recommendations against it: a retrospective cohort study. PloS One 2014, 9:e107352.
34. Cohn J.A., Wang C.E., Lakeman J.C., et al. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. Urologic oncology 2014, 32:41. e23-30.
35. Sayre E.C., Bunting P.S., Kopec J.A. Reliability of self-report versus chart-based prostate cancer, PSA, DRE and urinary symptoms. Can J Urol 2009, 16:4463-4471.
36. Hall H.I., Van Den Eeden S.K., Tolsma D.D., et al. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med 2004, 39:27-35.